NTHI
NeoncยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
NTHI Profile
Neonc Technologies Holdings, Inc.
A biopharmaceutical company specializing in the clinical stage of developing and treating intracranial malignant tumors
23975 Park Sorrento Suite 205 Calabasas, CA 91302
--
Neonc Technologies Holdings, Inc., incorporated on January 5, 2023, is a Delaware corporation. As a clinical-stage biopharmaceutical company, the company has been focusing on establishing treatments for intracranial malignancies, aggressive cancers located in the brain. These cancer types include primary brain cancers, such as glioblastoma, and secondary brain cancers, which spread through the metastasis of other cancers throughout the body, such as melanoma or breast and lung cancer. Localized malignancies of the brain are particularly difficult to treat because the blood-brain barrier prevents most drug therapies from entering the brain effectively. Therefore, these patients face the problem of poor prognosis and shortened average life expectancy. NeOnc is developing new drug delivery methods for use in combination with new drug candidates.
